Back to Agenda
SESSION 11 part 1: STATUS AND CHANGES IN RELATION TO CURRENT DISCLOSURE REQUIREMENTS IN EU AND THE USA
Session Chair(s)
Merete Joergensen, MBA, MSc
Clinical Disclosure and Transparency Expert, Merete-J Consulting, Denmark
Speaker(s)
Update of EU Country Registries/Requirements
Tom Bosch, PhD
Director, Clinical Registry, Netherlands
EU PASS/PAES Requirements for Disclosure
Thomas Goedecke, PharmD, PhD
Senior Pharmacovigilance Specialist, European Medicines Agency, Netherlands
Have an account?